85股获券商推荐，恒瑞医药目标价涨幅超52%

Group 1 - The core viewpoint of the article highlights the target price increases for certain listed companies, with Heng Rui Pharmaceutical, Lens Technology, and Weichai Power leading the rankings with target price increases of 52.03%, 36.05%, and 31.00% respectively [2] - On November 10, a total of 85 listed companies received recommendations from brokerages, indicating a positive sentiment in the market [2] - Among the recommended companies, Zhongtung High-tech received recommendations from 2 brokerages, while China Energy Construction and Urban Development received recommendations from 1 brokerage each [2]